jarrow rogovin

05 Sep: FDA Must Withdraw NDI Guidance or Extend Comment Period to July 2012

By James J. Gormley In our August 23rd post, we alerted you to a U.S. Food and Drug Administration (FDA) draft guidance on “new” dietary ingredients. We recommended that our 100,000+ members ask the FDA to withdraw the guidance and to not adopt the policies underpinning the interpretation behind this “guidance” in its review and enforcement activities. In the meantime,…